Performance evaluation of CXCL10 ELISA “cosmic” kit to measure CXCL10 in cerebrospinal fluid of patients with HTLV‐1‐associated myelopathy

Documenti analoghi

• Successful treatment with plasmapheresis of severe Bickerstaff brainstem encephalitis with high cerebrospinal fluid CXCL‐10 levels after COVID‐19 infection: A case report
  di: Naoki Iijima, et al.
  Pubblicazione: (2024)
• Human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications
  di: Makoto Nakashima, et al.
  Pubblicazione: (2025)
• Unveiling the Mysteries of Rare Neuroimmunological Disorders
  di: Yoshihisa Yamano
  Pubblicazione: (2025)
• Exploring digital biomarkers using smartphones for fatigue assessment in patients with multiple sclerosis
  di: Kenzo Sakurai, et al.
  Pubblicazione: (2024)
• Effect of Disease‐Modifying Treatments in Japanese Patients With Multiple Sclerosis During the Coronavirus Disease 2019 Pandemic
  di: Taisuke Ogawa, et al.
  Pubblicazione: (2025)